Teligent, Inc.
Teligent, Inc. TLGT Peers
See (TLGT) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TLGT | $0.17 | -13.85% | 0 | -0.04 | -$4.31 | N/A |
| ZTS | $167.12 | +1.52% | 74.4B | 30.06 | $5.56 | +1.13% |
| HLN | $10.89 | +0.09% | 49.6B | 25.93 | $0.42 | +1.54% |
| TAK | $15.25 | +1.30% | 48B | 66.28 | $0.23 | +3.91% |
| TEVA | $17.60 | -2.60% | 20.2B | -15.30 | -$1.15 | N/A |
| ITCI | $131.87 | N/A | 14B | -180.64 | -$0.73 | N/A |
| RDY | $15.89 | +1.63% | 13.2B | 20.11 | $0.79 | +0.61% |
| NBIX | $124.77 | -0.76% | 12.3B | 42.29 | $2.95 | N/A |
| CTLT | $63.48 | N/A | 11.5B | -27.84 | -$2.28 | N/A |
| VTRS | $9.04 | +2.61% | 10.6B | -2.84 | -$3.18 | +5.41% |
Stock Comparison
TLGT vs ZTS Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ZTS has a market cap of 74.4B. Regarding current trading prices, TLGT is priced at $0.17, while ZTS trades at $167.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ZTS's P/E ratio is 30.06. In terms of profitability, TLGT's ROE is +0.00%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, TLGT is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs HLN Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, HLN has a market cap of 49.6B. Regarding current trading prices, TLGT is priced at $0.17, while HLN trades at $10.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas HLN's P/E ratio is 25.93. In terms of profitability, TLGT's ROE is +0.00%, compared to HLN's ROE of +0.09%. Regarding short-term risk, TLGT is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TAK Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TAK has a market cap of 48B. Regarding current trading prices, TLGT is priced at $0.17, while TAK trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TAK's P/E ratio is 66.28. In terms of profitability, TLGT's ROE is +0.00%, compared to TAK's ROE of +0.04%. Regarding short-term risk, TLGT is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TEVA Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TEVA has a market cap of 20.2B. Regarding current trading prices, TLGT is priced at $0.17, while TEVA trades at $17.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TEVA's P/E ratio is -15.30. In terms of profitability, TLGT's ROE is +0.00%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, TLGT is more volatile compared to TEVA. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ITCI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ITCI has a market cap of 14B. Regarding current trading prices, TLGT is priced at $0.17, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ITCI's P/E ratio is -180.64. In terms of profitability, TLGT's ROE is +0.00%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, TLGT is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs RDY Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, RDY has a market cap of 13.2B. Regarding current trading prices, TLGT is priced at $0.17, while RDY trades at $15.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas RDY's P/E ratio is 20.11. In terms of profitability, TLGT's ROE is +0.00%, compared to RDY's ROE of +0.18%. Regarding short-term risk, TLGT is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs NBIX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, NBIX has a market cap of 12.3B. Regarding current trading prices, TLGT is priced at $0.17, while NBIX trades at $124.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas NBIX's P/E ratio is 42.29. In terms of profitability, TLGT's ROE is +0.00%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, TLGT is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs CTLT Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, CTLT has a market cap of 11.5B. Regarding current trading prices, TLGT is priced at $0.17, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas CTLT's P/E ratio is -27.84. In terms of profitability, TLGT's ROE is +0.00%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, TLGT is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs VTRS Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, VTRS has a market cap of 10.6B. Regarding current trading prices, TLGT is priced at $0.17, while VTRS trades at $9.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas VTRS's P/E ratio is -2.84. In terms of profitability, TLGT's ROE is +0.00%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, TLGT is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs RGC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, RGC has a market cap of 8B. Regarding current trading prices, TLGT is priced at $0.17, while RGC trades at $614.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas RGC's P/E ratio is -1807.88. In terms of profitability, TLGT's ROE is +0.00%, compared to RGC's ROE of -0.25%. Regarding short-term risk, TLGT is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for TLGT.
TLGT vs ELAN Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ELAN has a market cap of 7.1B. Regarding current trading prices, TLGT is priced at $0.17, while ELAN trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ELAN's P/E ratio is 19.07. In terms of profitability, TLGT's ROE is +0.00%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, TLGT is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs LNTH Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, LNTH has a market cap of 5.6B. Regarding current trading prices, TLGT is priced at $0.17, while LNTH trades at $80.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas LNTH's P/E ratio is 22.91. In terms of profitability, TLGT's ROE is +0.00%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, TLGT is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs PRGO Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, PRGO has a market cap of 3.8B. Regarding current trading prices, TLGT is priced at $0.17, while PRGO trades at $27.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas PRGO's P/E ratio is -23.01. In terms of profitability, TLGT's ROE is +0.00%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, TLGT is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs AMRX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, AMRX has a market cap of 3.4B. Regarding current trading prices, TLGT is priced at $0.17, while AMRX trades at $7.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas AMRX's P/E ratio is -195.25. In terms of profitability, TLGT's ROE is +0.00%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, TLGT is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ALVOW Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ALVOW has a market cap of 3.2B. Regarding current trading prices, TLGT is priced at $0.17, while ALVOW trades at $2.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ALVOW's P/E ratio is N/A. In terms of profitability, TLGT's ROE is +0.00%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, TLGT is more volatile compared to ALVOW. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ALVO Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ALVO has a market cap of 3.1B. Regarding current trading prices, TLGT is priced at $0.17, while ALVO trades at $10.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ALVO's P/E ratio is 28.03. In terms of profitability, TLGT's ROE is +0.00%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, TLGT is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs BGM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, BGM has a market cap of 3B. Regarding current trading prices, TLGT is priced at $0.17, while BGM trades at $16.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas BGM's P/E ratio is -81.80. In terms of profitability, TLGT's ROE is +0.00%, compared to BGM's ROE of -0.03%. Regarding short-term risk, TLGT is more volatile compared to BGM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs HCM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, HCM has a market cap of 2.9B. Regarding current trading prices, TLGT is priced at $0.17, while HCM trades at $16.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas HCM's P/E ratio is 84.20. In terms of profitability, TLGT's ROE is +0.00%, compared to HCM's ROE of +0.05%. Regarding short-term risk, TLGT is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs DCPH Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, DCPH has a market cap of 2.2B. Regarding current trading prices, TLGT is priced at $0.17, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas DCPH's P/E ratio is -11.58. In terms of profitability, TLGT's ROE is +0.00%, compared to DCPH's ROE of -0.28%. Regarding short-term risk, TLGT is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs EMBCV Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, EMBCV has a market cap of 1.9B. Regarding current trading prices, TLGT is priced at $0.17, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas EMBCV's P/E ratio is N/A. In terms of profitability, TLGT's ROE is +0.00%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, TLGT is more volatile compared to EMBCV. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs BHC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, BHC has a market cap of 1.9B. Regarding current trading prices, TLGT is priced at $0.17, while BHC trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas BHC's P/E ratio is -42.42. In terms of profitability, TLGT's ROE is +0.00%, compared to BHC's ROE of +0.05%. Regarding short-term risk, TLGT is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SUPN Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SUPN has a market cap of 1.9B. Regarding current trading prices, TLGT is priced at $0.17, while SUPN trades at $33.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SUPN's P/E ratio is 29.96. In terms of profitability, TLGT's ROE is +0.00%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, TLGT is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs INDV Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, INDV has a market cap of 1.7B. Regarding current trading prices, TLGT is priced at $0.17, while INDV trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas INDV's P/E ratio is -273.80. In terms of profitability, TLGT's ROE is +0.00%, compared to INDV's ROE of -0.01%. Regarding short-term risk, TLGT is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TARO Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TARO has a market cap of 1.6B. Regarding current trading prices, TLGT is priced at $0.17, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TARO's P/E ratio is 30.05. In terms of profitability, TLGT's ROE is +0.00%, compared to TARO's ROE of +0.02%. Regarding short-term risk, TLGT is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs EVO Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, EVO has a market cap of 1.5B. Regarding current trading prices, TLGT is priced at $0.17, while EVO trades at $4.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas EVO's P/E ratio is -6.16. In terms of profitability, TLGT's ROE is +0.00%, compared to EVO's ROE of -0.22%. Regarding short-term risk, TLGT is more volatile compared to EVO. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ANIP Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ANIP has a market cap of 1.4B. Regarding current trading prices, TLGT is priced at $0.17, while ANIP trades at $62.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ANIP's P/E ratio is -51.53. In terms of profitability, TLGT's ROE is +0.00%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, TLGT is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs AMPH Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, AMPH has a market cap of 1.3B. Regarding current trading prices, TLGT is priced at $0.17, while AMPH trades at $26.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas AMPH's P/E ratio is 9.58. In terms of profitability, TLGT's ROE is +0.00%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, TLGT is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs DVAX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, DVAX has a market cap of 1.3B. Regarding current trading prices, TLGT is priced at $0.17, while DVAX trades at $10.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas DVAX's P/E ratio is -20.86. In terms of profitability, TLGT's ROE is +0.00%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, TLGT is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs PCRX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, PCRX has a market cap of 1.2B. Regarding current trading prices, TLGT is priced at $0.17, while PCRX trades at $24.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas PCRX's P/E ratio is -11.10. In terms of profitability, TLGT's ROE is +0.00%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, TLGT is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs HROW Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, HROW has a market cap of 1.1B. Regarding current trading prices, TLGT is priced at $0.17, while HROW trades at $31.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas HROW's P/E ratio is -51.10. In terms of profitability, TLGT's ROE is +0.00%, compared to HROW's ROE of -0.36%. Regarding short-term risk, TLGT is more volatile compared to HROW. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs AVDL Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, AVDL has a market cap of 989.6M. Regarding current trading prices, TLGT is priced at $0.17, while AVDL trades at $10.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas AVDL's P/E ratio is -39.35. In terms of profitability, TLGT's ROE is +0.00%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, TLGT is more volatile compared to AVDL. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs PAHC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, PAHC has a market cap of 986.6M. Regarding current trading prices, TLGT is priced at $0.17, while PAHC trades at $24.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas PAHC's P/E ratio is 31.21. In terms of profitability, TLGT's ROE is +0.00%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, TLGT is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs COLL Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, COLL has a market cap of 976.2M. Regarding current trading prices, TLGT is priced at $0.17, while COLL trades at $30.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas COLL's P/E ratio is 24.89. In terms of profitability, TLGT's ROE is +0.00%, compared to COLL's ROE of +0.19%. Regarding short-term risk, TLGT is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs PETQ Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, PETQ has a market cap of 919.2M. Regarding current trading prices, TLGT is priced at $0.17, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas PETQ's P/E ratio is 83.73. In terms of profitability, TLGT's ROE is +0.00%, compared to PETQ's ROE of +0.05%. Regarding short-term risk, TLGT is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs CRON Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, CRON has a market cap of 751.6M. Regarding current trading prices, TLGT is priced at $0.17, while CRON trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas CRON's P/E ratio is 13.93. In terms of profitability, TLGT's ROE is +0.00%, compared to CRON's ROE of +0.05%. Regarding short-term risk, TLGT is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs EOLS Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, EOLS has a market cap of 636.4M. Regarding current trading prices, TLGT is priced at $0.17, while EOLS trades at $9.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas EOLS's P/E ratio is -11.09. In terms of profitability, TLGT's ROE is +0.00%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, TLGT is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs EMBC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, EMBC has a market cap of 592M. Regarding current trading prices, TLGT is priced at $0.17, while EMBC trades at $10.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas EMBC's P/E ratio is 11.38. In terms of profitability, TLGT's ROE is +0.00%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, TLGT is more volatile compared to EMBC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs BDSI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, BDSI has a market cap of 577.1M. Regarding current trading prices, TLGT is priced at $0.17, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas BDSI's P/E ratio is 6.82. In terms of profitability, TLGT's ROE is +0.00%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, TLGT is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SIGA Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SIGA has a market cap of 444.4M. Regarding current trading prices, TLGT is priced at $0.17, while SIGA trades at $6.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SIGA's P/E ratio is 9.28. In terms of profitability, TLGT's ROE is +0.00%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, TLGT is more volatile compared to SIGA. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ORGO Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ORGO has a market cap of 440.2M. Regarding current trading prices, TLGT is priced at $0.17, while ORGO trades at $3.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ORGO's P/E ratio is -21.69. In terms of profitability, TLGT's ROE is +0.00%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, TLGT is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TLRY Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TLRY has a market cap of 430.4M. Regarding current trading prices, TLGT is priced at $0.17, while TLRY trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TLRY's P/E ratio is -0.38. In terms of profitability, TLGT's ROE is +0.00%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, TLGT is more volatile compared to TLRY. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs KMDA Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, KMDA has a market cap of 402M. Regarding current trading prices, TLGT is priced at $0.17, while KMDA trades at $6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas KMDA's P/E ratio is 24.96. In terms of profitability, TLGT's ROE is +0.00%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, TLGT is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs EBS Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, EBS has a market cap of 366.9M. Regarding current trading prices, TLGT is priced at $0.17, while EBS trades at $6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas EBS's P/E ratio is -2.62. In terms of profitability, TLGT's ROE is +0.00%, compared to EBS's ROE of -0.27%. Regarding short-term risk, TLGT is more volatile compared to EBS. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs AQST Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, AQST has a market cap of 355.6M. Regarding current trading prices, TLGT is priced at $0.17, while AQST trades at $3.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas AQST's P/E ratio is -6.17. In terms of profitability, TLGT's ROE is +0.00%, compared to AQST's ROE of +1.07%. Regarding short-term risk, TLGT is more volatile compared to AQST. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SNDL Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SNDL has a market cap of 339.6M. Regarding current trading prices, TLGT is priced at $0.17, while SNDL trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SNDL's P/E ratio is -4.40. In terms of profitability, TLGT's ROE is +0.00%, compared to SNDL's ROE of -0.09%. Regarding short-term risk, TLGT is more volatile compared to SNDL. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ACB Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ACB has a market cap of 326.6M. Regarding current trading prices, TLGT is priced at $0.17, while ACB trades at $5.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ACB's P/E ratio is 29.75. In terms of profitability, TLGT's ROE is +0.00%, compared to ACB's ROE of +0.02%. Regarding short-term risk, TLGT is more volatile compared to ACB. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TKNO Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TKNO has a market cap of 315.8M. Regarding current trading prices, TLGT is priced at $0.17, while TKNO trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TKNO's P/E ratio is -12.85. In terms of profitability, TLGT's ROE is +0.00%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, TLGT is more volatile compared to TKNO. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs CGC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, CGC has a market cap of 311.5M. Regarding current trading prices, TLGT is priced at $0.17, while CGC trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas CGC's P/E ratio is -0.36. In terms of profitability, TLGT's ROE is +0.00%, compared to CGC's ROE of -1.13%. Regarding short-term risk, TLGT is more volatile compared to CGC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ALIM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ALIM has a market cap of 301.3M. Regarding current trading prices, TLGT is priced at $0.17, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ALIM's P/E ratio is 5.28. In terms of profitability, TLGT's ROE is +0.00%, compared to ALIM's ROE of -0.32%. Regarding short-term risk, TLGT is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ZYBT Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ZYBT has a market cap of 296.2M. Regarding current trading prices, TLGT is priced at $0.17, while ZYBT trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ZYBT's P/E ratio is 104.17. In terms of profitability, TLGT's ROE is +0.00%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, TLGT is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for TLGT.
TLGT vs LNDC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, LNDC has a market cap of 263.6M. Regarding current trading prices, TLGT is priced at $0.17, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas LNDC's P/E ratio is -4.04. In terms of profitability, TLGT's ROE is +0.00%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, TLGT is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs LFCR Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, LFCR has a market cap of 254M. Regarding current trading prices, TLGT is priced at $0.17, while LFCR trades at $6.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas LFCR's P/E ratio is -4.67. In terms of profitability, TLGT's ROE is +0.00%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, TLGT is more volatile compared to LFCR. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ESPR Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ESPR has a market cap of 241.8M. Regarding current trading prices, TLGT is priced at $0.17, while ESPR trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ESPR's P/E ratio is -1.44. In terms of profitability, TLGT's ROE is +0.00%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, TLGT is more volatile compared to ESPR. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TYHT Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TYHT has a market cap of 229.2M. Regarding current trading prices, TLGT is priced at $0.17, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TYHT's P/E ratio is -1.61. In terms of profitability, TLGT's ROE is +0.00%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, TLGT is more volatile compared to TYHT. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs OGI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, OGI has a market cap of 191.5M. Regarding current trading prices, TLGT is priced at $0.17, while OGI trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas OGI's P/E ratio is 11.00. In terms of profitability, TLGT's ROE is +0.00%, compared to OGI's ROE of +0.05%. Regarding short-term risk, TLGT is more volatile compared to OGI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs REPH Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, REPH has a market cap of 177.4M. Regarding current trading prices, TLGT is priced at $0.17, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas REPH's P/E ratio is -8.04. In terms of profitability, TLGT's ROE is +0.00%, compared to REPH's ROE of -0.22%. Regarding short-term risk, TLGT is more volatile compared to REPH. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs DERM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, DERM has a market cap of 170.1M. Regarding current trading prices, TLGT is priced at $0.17, while DERM trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas DERM's P/E ratio is -19.73. In terms of profitability, TLGT's ROE is +0.00%, compared to DERM's ROE of -0.52%. Regarding short-term risk, TLGT is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs BIOA Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, BIOA has a market cap of 157M. Regarding current trading prices, TLGT is priced at $0.17, while BIOA trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas BIOA's P/E ratio is -2.21. In terms of profitability, TLGT's ROE is +0.00%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, TLGT is more volatile compared to BIOA. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs IRWD Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, IRWD has a market cap of 129.3M. Regarding current trading prices, TLGT is priced at $0.17, while IRWD trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas IRWD's P/E ratio is -4.21. In terms of profitability, TLGT's ROE is +0.00%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, TLGT is less volatile compared to IRWD. This indicates potentially lower risk in terms of short-term price fluctuations for TLGT.
TLGT vs CRDL Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, CRDL has a market cap of 119.8M. Regarding current trading prices, TLGT is priced at $0.17, while CRDL trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas CRDL's P/E ratio is -4.26. In terms of profitability, TLGT's ROE is +0.00%, compared to CRDL's ROE of -2.08%. Regarding short-term risk, TLGT is more volatile compared to CRDL. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs THTX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, THTX has a market cap of 118.6M. Regarding current trading prices, TLGT is priced at $0.17, while THTX trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas THTX's P/E ratio is -36.86. In terms of profitability, TLGT's ROE is +0.00%, compared to THTX's ROE of +0.16%. Regarding short-term risk, TLGT is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SCTL Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SCTL has a market cap of 116.1M. Regarding current trading prices, TLGT is priced at $0.17, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SCTL's P/E ratio is -7.86. In terms of profitability, TLGT's ROE is +0.00%, compared to SCTL's ROE of -0.22%. Regarding short-term risk, TLGT is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs PROC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, PROC has a market cap of 114M. Regarding current trading prices, TLGT is priced at $0.17, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas PROC's P/E ratio is 1.53. In terms of profitability, TLGT's ROE is +0.00%, compared to PROC's ROE of -2.22%. Regarding short-term risk, TLGT is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs OPTN Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, OPTN has a market cap of 97.2M. Regarding current trading prices, TLGT is priced at $0.17, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas OPTN's P/E ratio is -4.42. In terms of profitability, TLGT's ROE is +0.00%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, TLGT is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ZOM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ZOM has a market cap of 95.3M. Regarding current trading prices, TLGT is priced at $0.17, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ZOM's P/E ratio is -1.62. In terms of profitability, TLGT's ROE is +0.00%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, TLGT is more volatile compared to ZOM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs GRVI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, GRVI has a market cap of 88.9M. Regarding current trading prices, TLGT is priced at $0.17, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas GRVI's P/E ratio is 26.05. In terms of profitability, TLGT's ROE is +0.00%, compared to GRVI's ROE of -5.25%. Regarding short-term risk, TLGT is more volatile compared to GRVI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs CPIX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, CPIX has a market cap of 82.4M. Regarding current trading prices, TLGT is priced at $0.17, while CPIX trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas CPIX's P/E ratio is -21.19. In terms of profitability, TLGT's ROE is +0.00%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, TLGT is more volatile compared to CPIX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ZYNE Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ZYNE has a market cap of 70.1M. Regarding current trading prices, TLGT is priced at $0.17, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, TLGT's ROE is +0.00%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, TLGT is more volatile compared to ZYNE. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs INCR Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, INCR has a market cap of 69.8M. Regarding current trading prices, TLGT is priced at $0.17, while INCR trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas INCR's P/E ratio is -3.52. In terms of profitability, TLGT's ROE is +0.00%, compared to INCR's ROE of -0.07%. Regarding short-term risk, TLGT is more volatile compared to INCR. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SSIC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SSIC has a market cap of 66.7M. Regarding current trading prices, TLGT is priced at $0.17, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SSIC's P/E ratio is 11.93. In terms of profitability, TLGT's ROE is +0.00%, compared to SSIC's ROE of +0.03%. Regarding short-term risk, TLGT is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ASRT Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ASRT has a market cap of 63.3M. Regarding current trading prices, TLGT is priced at $0.17, while ASRT trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ASRT's P/E ratio is -2.07. In terms of profitability, TLGT's ROE is +0.00%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, TLGT is more volatile compared to ASRT. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs VLNS Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, VLNS has a market cap of 61.5M. Regarding current trading prices, TLGT is priced at $0.17, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas VLNS's P/E ratio is -1.03. In terms of profitability, TLGT's ROE is +0.00%, compared to VLNS's ROE of N/A. Regarding short-term risk, TLGT is more volatile compared to VLNS. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SXTC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SXTC has a market cap of 54.9M. Regarding current trading prices, TLGT is priced at $0.17, while SXTC trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SXTC's P/E ratio is 0.02. In terms of profitability, TLGT's ROE is +0.00%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, TLGT is more volatile compared to SXTC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs JUPW Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, JUPW has a market cap of 49.3M. Regarding current trading prices, TLGT is priced at $0.17, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas JUPW's P/E ratio is -2.41. In terms of profitability, TLGT's ROE is +0.00%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, TLGT is more volatile compared to JUPW. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs QNTM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, QNTM has a market cap of 42.3M. Regarding current trading prices, TLGT is priced at $0.17, while QNTM trades at $14.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas QNTM's P/E ratio is -1.10. In terms of profitability, TLGT's ROE is +0.00%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, TLGT is more volatile compared to QNTM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs QLI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, QLI has a market cap of 38.7M. Regarding current trading prices, TLGT is priced at $0.17, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas QLI's P/E ratio is -4.92. In terms of profitability, TLGT's ROE is +0.00%, compared to QLI's ROE of -0.16%. Regarding short-term risk, TLGT is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs RMTI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, RMTI has a market cap of 35.2M. Regarding current trading prices, TLGT is priced at $0.17, while RMTI trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas RMTI's P/E ratio is -103.00. In terms of profitability, TLGT's ROE is +0.00%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, TLGT is more volatile compared to RMTI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SCYX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SCYX has a market cap of 34.4M. Regarding current trading prices, TLGT is priced at $0.17, while SCYX trades at $0.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SCYX's P/E ratio is -1.57. In terms of profitability, TLGT's ROE is +0.00%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, TLGT is more volatile compared to SCYX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs HEXO Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, HEXO has a market cap of 31.2M. Regarding current trading prices, TLGT is priced at $0.17, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas HEXO's P/E ratio is -0.26. In terms of profitability, TLGT's ROE is +0.00%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, TLGT is more volatile compared to HEXO. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs KALA Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, KALA has a market cap of 30.6M. Regarding current trading prices, TLGT is priced at $0.17, while KALA trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas KALA's P/E ratio is -0.64. In terms of profitability, TLGT's ROE is +0.00%, compared to KALA's ROE of -3.69%. Regarding short-term risk, TLGT is more volatile compared to KALA. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs GELS Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, GELS has a market cap of 27.8M. Regarding current trading prices, TLGT is priced at $0.17, while GELS trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas GELS's P/E ratio is -12.29. In terms of profitability, TLGT's ROE is +0.00%, compared to GELS's ROE of -0.21%. Regarding short-term risk, TLGT is less volatile compared to GELS. This indicates potentially lower risk in terms of short-term price fluctuations for TLGT.
TLGT vs EGRX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, EGRX has a market cap of 25.9M. Regarding current trading prices, TLGT is priced at $0.17, while EGRX trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas EGRX's P/E ratio is 2.35. In terms of profitability, TLGT's ROE is +0.00%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, TLGT is more volatile compared to EGRX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs CYTH Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, CYTH has a market cap of 23.6M. Regarding current trading prices, TLGT is priced at $0.17, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas CYTH's P/E ratio is -0.80. In terms of profitability, TLGT's ROE is +0.00%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, TLGT is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs IXHL Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, IXHL has a market cap of 19.9M. Regarding current trading prices, TLGT is priced at $0.17, while IXHL trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas IXHL's P/E ratio is -0.17. In terms of profitability, TLGT's ROE is +0.00%, compared to IXHL's ROE of -2.03%. Regarding short-term risk, TLGT is more volatile compared to IXHL. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs DRRX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, DRRX has a market cap of 17.8M. Regarding current trading prices, TLGT is priced at $0.17, while DRRX trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas DRRX's P/E ratio is -1.20. In terms of profitability, TLGT's ROE is +0.00%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, TLGT is more volatile compared to DRRX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs FLGC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, FLGC has a market cap of 15.6M. Regarding current trading prices, TLGT is priced at $0.17, while FLGC trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas FLGC's P/E ratio is -0.72. In terms of profitability, TLGT's ROE is +0.00%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, TLGT is more volatile compared to FLGC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs ACRX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, ACRX has a market cap of 14.6M. Regarding current trading prices, TLGT is priced at $0.17, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas ACRX's P/E ratio is -0.31. In terms of profitability, TLGT's ROE is +0.00%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, TLGT is more volatile compared to ACRX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs PRPH Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, PRPH has a market cap of 14.5M. Regarding current trading prices, TLGT is priced at $0.17, while PRPH trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas PRPH's P/E ratio is -0.16. In terms of profitability, TLGT's ROE is +0.00%, compared to PRPH's ROE of -1.59%. Regarding short-term risk, TLGT is more volatile compared to PRPH. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs COSM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, COSM has a market cap of 14.3M. Regarding current trading prices, TLGT is priced at $0.17, while COSM trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas COSM's P/E ratio is -0.45. In terms of profitability, TLGT's ROE is +0.00%, compared to COSM's ROE of -0.51%. Regarding short-term risk, TLGT is more volatile compared to COSM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TXMD Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TXMD has a market cap of 14M. Regarding current trading prices, TLGT is priced at $0.17, while TXMD trades at $1.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TXMD's P/E ratio is -6.37. In terms of profitability, TLGT's ROE is +0.00%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, TLGT is more volatile compared to TXMD. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs AYTU Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, AYTU has a market cap of 12.5M. Regarding current trading prices, TLGT is priced at $0.17, while AYTU trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas AYTU's P/E ratio is -1.36. In terms of profitability, TLGT's ROE is +0.00%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, TLGT is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs TLPH Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, TLPH has a market cap of 10.5M. Regarding current trading prices, TLGT is priced at $0.17, while TLPH trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas TLPH's P/E ratio is -1.16. In terms of profitability, TLGT's ROE is +0.00%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, TLGT is more volatile compared to TLPH. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs AGRX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, AGRX has a market cap of 10.4M. Regarding current trading prices, TLGT is priced at $0.17, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas AGRX's P/E ratio is -0.89. In terms of profitability, TLGT's ROE is +0.00%, compared to AGRX's ROE of +0.93%. Regarding short-term risk, TLGT is more volatile compared to AGRX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SISI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SISI has a market cap of 9.1M. Regarding current trading prices, TLGT is priced at $0.17, while SISI trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SISI's P/E ratio is N/A. In terms of profitability, TLGT's ROE is +0.00%, compared to SISI's ROE of -1.41%. Regarding short-term risk, TLGT is more volatile compared to SISI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs IMCC Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, IMCC has a market cap of 9M. Regarding current trading prices, TLGT is priced at $0.17, while IMCC trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas IMCC's P/E ratio is -1.91. In terms of profitability, TLGT's ROE is +0.00%, compared to IMCC's ROE of -1.52%. Regarding short-term risk, TLGT is more volatile compared to IMCC. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs NLTX Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, NLTX has a market cap of 8.2M. Regarding current trading prices, TLGT is priced at $0.17, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas NLTX's P/E ratio is -0.28. In terms of profitability, TLGT's ROE is +0.00%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, TLGT is more volatile compared to NLTX. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs SBFM Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, SBFM has a market cap of 7.7M. Regarding current trading prices, TLGT is priced at $0.17, while SBFM trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas SBFM's P/E ratio is -0.29. In terms of profitability, TLGT's ROE is +0.00%, compared to SBFM's ROE of -0.21%. Regarding short-term risk, TLGT is more volatile compared to SBFM. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs YCBD Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, YCBD has a market cap of 7.6M. Regarding current trading prices, TLGT is priced at $0.17, while YCBD trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas YCBD's P/E ratio is 0.01. In terms of profitability, TLGT's ROE is +0.00%, compared to YCBD's ROE of -0.01%. Regarding short-term risk, TLGT is more volatile compared to YCBD. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.
TLGT vs LCI Comparison
TLGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLGT stands at 0. In comparison, LCI has a market cap of 7.4M. Regarding current trading prices, TLGT is priced at $0.17, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLGT currently has a P/E ratio of -0.04, whereas LCI's P/E ratio is -0.04. In terms of profitability, TLGT's ROE is +0.00%, compared to LCI's ROE of +1.66%. Regarding short-term risk, TLGT is more volatile compared to LCI. This indicates potentially higher risk in terms of short-term price fluctuations for TLGT.